Board of Scientific Counselors, Center for Preparedness and Response, (BSC, CPR), 18533-18534 [2021-07284]

Download as PDF Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This virtual meeting is open to the public, limited only by audio and web conference lines (300 audio and web conference lines are available). Registration is required. To register for this web conference, please go to: www.cdc.gov/hicpac. All registered participants will receive the meeting link and instructions shortly before the meeting. DATES: The meeting will be held on June 3, 2021, from 9:00 a.m. to 3:00 p.m., EDT. SUMMARY: Please click the link below to join the webinar: https:// cdc.zoomgov.com/j/1612908106? pwd=M0xTVWxmUTRtZXhu OVBzWmsybFZxZz09. Meeting ID: 161 290 8106 Passcode: yq!BLL44 Dial-in Lines: +1–669–254–5252 (San Jose) +1–646–828–7666 (New York) Meeting ID: 161 290 8106 Telephone Passcode: 47632330. ADDRESSES: KooWhang Chung, M.P.H., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027, Telephone: (404) 498–0730; Email: HICPAC@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention FOR FURTHER INFORMATION CONTACT: VerDate Sep<11>2014 17:45 Apr 08, 2021 Jkt 253001 of healthcare-associated infections and healthcare-related conditions. Matters To Be Considered: The agenda will include the following updates: The Healthcare Personnel Guideline Workgroup; the Long-term Care/Postacute Care Workgroup; and the Neonatal Intensive Care Unit Workgroup. Agenda items are subject to change as priorities dictate. Procedures for Public Comment: Time will be available for public comment. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Please note that the public comment period may end before the time indicated, following the last call for comments. Procedures for Written Comment: The public may submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed above. The deadline for receipt of written public comment is May 25, 2021. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length. Written comments received in advance of the meeting will be included in the official record of the meeting. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–07286 Filed 4–8–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Center for Preparedness and Response, (BSC, CPR) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 18533 In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Center for Preparedness and Response, (BSC, CPR). This is a virtual meeting that is open to the public, limited only by the number of net conference access available, which is 500. Pre-registration is required by accessing the link at: https://cdc.zoomgov.com/webinar/ register/WN_OwjXZIdgSRK_ yea6iSTs4Q. SUMMARY: The meeting will be held on May 19, 2021, from 12:30 p.m. to 3:30 p.m., EDT and May 20, 2021, from 12:30 p.m. to 2:30 p.m., EDT. DATES: Zoom Virtual Meeting. Instructions to access the Zoom virtual meeting will be provided in the link following registration. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and Public Health Practice, CDC, 1600 Clifton Road NE, Mailstop–H21–6, Atlanta, Georgia 30329–4027, Telephone: (404) 639–7450; Facsimile: (678) 669–1667; Email: OPHPR.BSC.Questions@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Center for Preparedness and Response (CPR), concerning strategies and goals for the programs and research within CPR, monitoring the overall strategic direction and focus of the CPR Divisions and Offices, and administration and oversight of peer review for CPR scientific programs. For additional information about the Board, please visit: https://www.cdc.gov/cpr/bsc/ index.htm. Matters To Be Considered: The agenda will include: Day 1—(1) CPR Director Update and (2) CPR Division Updates and Discussion. Day 2—(1) CPR Polio Containment Workgroup (PCWG) Update and (2) CPR Research Portfolio Update and Future Initiatives. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\09APN1.SGM 09APN1 18534 Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–07284 Filed 4–8–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2021–0039] Draft Recommendations for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients: Central Line-Associated Blood Stream Infections (CLABSI) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (DHHS), announces the opening of a docket to obtain comment on the Draft Recommendations for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients: Central Line-associated Blood Stream Infections (CLABSI). (‘‘Draft Guideline’’). The Draft Guideline provides new, evidence-based recommendations specific to the prevention and control of central lineassociated blood stream infections (CLABSI) in neonatal intensive care unit (NICU) patients. DATES: Written comments must be received on or before June 8, 2021. ADDRESSES: You may submit comments, identified by Docket No. CDC–2021– 0039, by any of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Attn: Docket No. CDC– 2021–0039, HICPAC Secretariat, 1600 Clifton Rd. NE, Mailstop H16–2, Atlanta, Georgia, 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to https://regulations.gov, including any personal information provided. For access to the docket to read background SUMMARY: VerDate Sep<11>2014 17:45 Apr 08, 2021 Jkt 253001 documents or comments received, go to https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Marwan Wassef, M.P.H., Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16–2, Atlanta, Georgia, 30329; Email: IPCGuidelines@ cdc.gov; Telephone: (404) 639–4000. SUPPLEMENTARY INFORMATION: Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to the Draft Guideline. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted in preparation of the final Guideline for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients and may revise the final document as appropriate. Background The Draft Guideline, located in the ‘‘Supporting & Related Material’’ tab of the docket, provides new, evidencebased recommendations specific to the prevention and control of CLABSI in NICU patients, including insertion and maintenance practices. The Draft Guideline is intended for use by infection prevention staff, healthcare epidemiologists, healthcare administrators, nurses, neonatologists, other healthcare providers, and persons responsible for developing, implementing, and evaluating infection prevention and control programs for NICUs. The guideline can also serve as a resource for societies or organizations to develop more detailed implementation guidance for the prevention of infection in NICU patients. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 The Healthcare Infection Control Practices Advisory Committee (HICPAC), a federal advisory committee chartered to provide advice and guidance to the CDC, worked with national partners, academicians, public health professionals, healthcare providers, and other partners to develop this Draft Guideline. HICPAC includes representatives from public health, infectious diseases, regulatory and other federal agencies, professional societies, and other stakeholders. The draft recommendations in this Draft Guideline are informed by a systematic review of the best available literature through February 2017 and of relevant references published since February 2017 suggested by subject matter experts. This Draft Guideline will not be a federal rule or regulation. Dated: April 6, 2021. Sandra Cashman, Executive Secretary, Centers for Disease Control and Prevention. [FR Doc. 2021–07337 Filed 4–8–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10209, CMS– 10701, CMS–10516, CMS–855O and CMS– 216–94] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and SUMMARY: E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 86, Number 67 (Friday, April 9, 2021)]
[Notices]
[Pages 18533-18534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07284]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Center for Preparedness and 
Response, (BSC, CPR)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
Center for Preparedness and Response, (BSC, CPR). This is a virtual 
meeting that is open to the public, limited only by the number of net 
conference access available, which is 500. Pre-registration is required 
by accessing the link at: https://cdc.zoomgov.com/webinar/register/WN_OwjXZIdgSRK_yea6iSTs4Q.

DATES: The meeting will be held on May 19, 2021, from 12:30 p.m. to 
3:30 p.m., EDT and May 20, 2021, from 12:30 p.m. to 2:30 p.m., EDT.

ADDRESSES: Zoom Virtual Meeting. Instructions to access the Zoom 
virtual meeting will be provided in the link following registration.

FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and 
Public Health Practice, CDC, 1600 Clifton Road NE, Mailstop-H21-6, 
Atlanta, Georgia 30329-4027, Telephone: (404) 639-7450; Facsimile: 
(678) 669-1667; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: This Board is charged with providing advice and guidance 
to the Secretary, Department of Health and Human Services (HHS), the 
Assistant Secretary for Health (ASH), the Director, Centers for Disease 
Control and Prevention (CDC), and the Director, Center for Preparedness 
and Response (CPR), concerning strategies and goals for the programs 
and research within CPR, monitoring the overall strategic direction and 
focus of the CPR Divisions and Offices, and administration and 
oversight of peer review for CPR scientific programs. For additional 
information about the Board, please visit: https://www.cdc.gov/cpr/bsc/index.htm.
    Matters To Be Considered: The agenda will include: Day 1--(1) CPR 
Director Update and (2) CPR Division Updates and Discussion. Day 2--(1) 
CPR Polio Containment Workgroup (PCWG) Update and (2) CPR Research 
Portfolio Update and Future Initiatives. Agenda items are subject to 
change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 18534]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-07284 Filed 4-8-21; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.